This page is part of the FHIR Shorthand (v3.0.0: Release 3 - Mixed Normative and STU) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version. For a full list of available versions, see the Directory of published versions
Official URL: http://hl7.org/fhir/uv/shorthand/ImplementationGuide/hl7.fhir.uv.shorthand | Version: 3.0.0 | |||
Draft as of 2024-08-19 | Computable Name: FHIRShorthand |
NOTE: Information on this page is informative content.
FHIR Shorthand (FSH) is a domain-specific language for defining HL7® FHIR® artifacts involved in creation of FHIR Implementation Guides (IG). The goal of FSH is to allow Implementation Guide (IG) creators to more directly express their intent with fewer concerns about underlying FHIR mechanics, and efficiently produce high-quality FHIR IGs.
Conceived in September 2019, with the first version of the specification released in March 2020, FSH has been rapidly adopted by the FHIR community. Since that time, several significant tools for processing FSH have been developed, including SUSHI, a reference implementation and de facto standard compiler for transforming FSH into FHIR artifacts. GoFSH, a tool for transforming FHIR artifacts to FSH, enables lossless round-tripping from FHIR JSON to FSH and back. FSH and SUSHI have been integrated with the HL7 FHIR Implementation Guide Publishing tool and Firely's Simplifier.net, allowing seamless processing from FSH to a complete IG.
As of March 2024:
FSH was approved as a Standard for Trial Use (STU 1) in May 2020 and a Mixed Normative/Trial Use Standard (R2) in February 2022 . In the ensuing period, additional activity around FSH has driven improvements, new features, and maturation of FSH and related tools. The majority of language features of FSH are now normative, but certain newer language features are proposed as Trial Use. Trial use features are clearly marked in the language specification with the TU symbol.
Designation as a normative standard does not mean that the FSH language will cease to evolve. Rather, it indicates that, except in very rare cases, future changes will be compatible with normative portions of the specification.
FSH was created in response to the need in the FHIR community for scalable, fast, user-friendly tools for IG creation and maintenance. IG authors often struggle to implement profiling projects with efficiency, consistency, and quality. Project teams iterate over the formal definitions and examples many times during the IG development process. As such, an agile approach to refactoring and revision is invaluable.
Aside from FSH, alternative methods for IG development include:
While recognizing there is no single "best" approach to IG development, experience across many domains has shown that complex software projects are typically approached with textual languages. As a language designed for the job of profiling and IG creation, FSH is concise, understandable, and aligned to user intentions. Users may find that the FSH language representation is a good way to understand a set of profiles or logical models. Because it is text-based, FSH brings a degree of editing agility not typically found in graphical tools (cutting and pasting, search and replace, spell checking, etc.) FSH is ideal for distributed development under source code control, providing meaningful version-to-version differentials, support for merging and conflict resolution, and nimble refactoring. These features allow FSH to scale in ways that other approaches cannot. Any text editor can be used to create or modify FSH, but advanced text editor plugins may also be used to further aid authoring.
The FSH IG includes the following information:
The following materials, useful for learning and applying FHIR Shorthand but not part of the language specification, are found on FSHSchool.org:
Note that the Language Reference is the formal specification, and if there is any conflict between that and any other written or programmatic materials, the former is considered the source of truth.
FHIR Shorthand follows the same modified semantic versioning approach as FHIR. See the documentation on versioning in FHIR Releases and Versioning for more detail. Implementers are encouraged to clearly indicate what version or versions of the FSH specification they implement.
FSH language issues and suggestions can be made in the HL7 Jira. When filing FSH language or IG issues, use project="FHIR" AND Specification = "Shorthand (FHIR) [FHIR-shorthand]".
SUSHI bugs, issues, and suggestions can be made here.
GoFSH bugs, issues, and suggestions can be made here.
If your FSH project is not listed in FSH Finder, log an issue here or submit a pull request on the list of organizations in settings.yml.
FSH examples for inclusion in FSH Online can be contributed here.
Role | Name | Organization | Contact |
---|---|---|---|
Author | Mark A. Kramer | MITRE Corporation | mkramer@mitre.org |
Author | Chris Moesel | MITRE Corporation | cmoesel@mitre.org |
Contributor | Julia K. Afeltra | MITRE Corporation | jafeltra@mitre.org |
Contributor | Julian A. Carter | MITRE Corporation | jacarter@mitre.org |
Contributor | Samantha Citron | MITRE Corporation | scitron@mitre.org |
Contributor | Nick Freiter | MITRE Corporation | nfreiter@mitre.org |
Contributor | Joe Paquette | athenahealth | jpaquette@athenahealth.com |
Contributor | Mint N. Thompson | MITRE Corporation | mathompson@mitre.org |
FHIR Infrastructure Co-chair | Rick Geimer | Lantana Consulting Group | rick.geimer@lantanagroup.com |
FHIR Infrastructure Co-chair | Josh Mandel | SMART Health IT | jmandel@gmail.com |
FHIR Infrastructure Co-chair | Lloyd McKenzie | HL7 Canada/Gevity | lloyd@lmckenzie.com |
FHIR Infrastructure Co-chair | Yunwei Wang | MITRE Corporation | yunweiw@mitre.org |
The authors gratefully acknowledge the many contributions from numerous users and facilitators who helped shape, mature, debug, and advance the FSH specification. The authors want to thank all those who participate on the shorthand channel via chat.fhir.org. While every discussion helps build the FSH knowledge base and strengthen the community of FSH, we especially appreciate those who provide answers and participate in design discussions. We therefore recognize:
Reece Adamson, Kurt Allen, Carl Anderson, Keith Boone, Giorgio Cangioli, Gino Canessa, Etienne Cantineau, Juan Manuel Caputo, Sam Citron, Sheila Connelly, Carmela Couderc, Stuart Cox, Nathan Davis, Bart Decuypere, Paul Denning, Noemi Deppenwiese, Mark Discenza, Jean Duteau, Oliver Egger, Brett Esler, Richard Esmond, Richard Ettema, Michael Faughn, Benjamin Flessner, Scott Fradkin, Sarah Gaunt, Nick George, Hugh Glover, Andy Gregorowicz, Grahame Grieve, Alex Goel, Nick Goupinets, John Grimes, Eric Haas, Torben Hagensen, Bill Harty, Rob Hausam, David Hay, Bret Heale, Simone Heckmann, Martin Höcker, Mark Iantorno, Brian Kaney, Daniel Karlsson, Richard Kavanagh, John Keyes, Max Körlinge, Ewout Kramer, Saul Kravitz, Halina Labikova, Patrick Langford, Michael Lawley, Carl Leitner, Hank Lenzi, Rutt Lindström, Geoff Low, Stephen MacVicar, Dylan Mahalingam, Rute Martins Baptista, Josh Mandel, Max Masnick, Lloyd McKenzie, Stuart McGrigor, Bob Milius, John Moehrke, Ryan Moehrke, Jabeen Mohammed, Sean Muir, Dipanjan Mukherjee, Muthu Muthuraj, Christian Nau, Craig Newman, Catherine Hosage Norman, Diana Ovelgoenne, Joe Paquette, Tom Parker-Shemilt, Janaka Peiris, Vadim Peretokin, Vassil Peytchev, Brian Postlethwaite, Caroline Potteiger, Mareike Przysucha, David Pyke, Andre Quina, Joshua Reynolds, Rob Reynolds, Bryn Rhodes, Andy Richardson, Peter Robinson, Kirstine Rosenbeck Gøeg, Thomas Tveit Rosenlund, Shovan Roy, Julian Sass, Michael Sauer, Mark Scrimshire, Larry Shields, John Silva, Elliot Silver, Igor Sirkovich, Bill Sorensen, Corey Spears, Richard Stanley, Lee Surprenant, Jose Costa Teixeira, May Terry, Arvid Thunholm, Eric Torstenson, Richard Townley-O'Neill, Conor Vahland, Pétur Valdimarsson, Bas van den Heuvel, Matthijs van der Wielen Bence Vass, Barbro Vessman, Jens Villadsen, Ward Weistra, Patrick Werner, Rien Wertheim, David Winters, Alexander Zautke, and Michaela Ziegler.
The authors apologize if they have omitted any contributor from this list.